| scholarly article | Q13442814 |
| P2093 | author name string | Kelvin O Lim | |
| Adolf Pfefferbaum | |||
| Edith V Sullivan | |||
| Margaret J Rosenbloom | |||
| Daniel H Mathalon | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alcoholism | Q15326 |
| schizophrenia | Q41112 | ||
| comorbidity | Q1414874 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 245-252 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Compounded brain volume deficits in schizophrenia-alcoholism comorbidity | |
| P478 | volume | 60 |
| Q50574430 | A magnetic resonance imaging family study of cortical thickness in schizophrenia. |
| Q45406181 | Alcohol Use Disorders Identification Test (AUDIT) scores are elevated in antipsychotic-induced hyperprolactinaemia |
| Q35175759 | Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia. |
| Q47882769 | Alcohol use is associated with thinner cerebral cortex and larger ventricles in schizophrenia, bipolar disorder and healthy controls |
| Q37497599 | An FMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia |
| Q31120592 | Are brain structural abnormalities useful as endophenotypes in schizophrenia? |
| Q57825253 | Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspective |
| Q26796401 | Auditory dysfunction in schizophrenia: integrating clinical and basic features |
| Q36756858 | Biologic Commonalities between Mental Illness and Addiction |
| Q30558464 | Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence |
| Q33870945 | Clinical and pathological features of alcohol-related brain damage |
| Q35839390 | Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. |
| Q34901749 | Comorbid substance abuse and brain morphology in recent-onset psychosis |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q37158533 | Deficient Suppression of Default Mode Regions during Working Memory in Individuals with Early Psychosis and at Clinical High-Risk for Psychosis |
| Q37627401 | Differential brain response to alcohol cue distractors across stages of alcohol dependence. |
| Q34282907 | Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies |
| Q36460207 | Evidence for white matter abnormalities in schizophrenia |
| Q46963028 | Executive function and memory in relation to olfactory deficits in alcohol-dependent patients |
| Q48118197 | Impulsivity-related brain volume deficits in schizophrenia-addiction comorbidity |
| Q30873588 | In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia |
| Q47780196 | Light alcohol intake during adolescence induces alcohol addiction in a neurodevelopmental model of schizophrenia. |
| Q94544886 | Metaphor Processing Dysfunctions in Schizophrenia Patients With and Without Substance Use Disorders |
| Q31027922 | Neurobiological correlates of violent behavior among persons with schizophrenia |
| Q36703795 | Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications |
| Q46909505 | Neuropsychological and sensory gating deficits related to remote alcohol abuse history in schizophrenia |
| Q37417633 | Pyramidal neuron number in layer 3 of primary auditory cortex of subjects with schizophrenia. |
| Q34335555 | Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder |
| Q24658134 | Reduced dendritic spine density in auditory cortex of subjects with schizophrenia |
| Q41189606 | Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis |
| Q37807614 | Schizophrenia: Current Therapy and Review |
| Q58190109 | Schizophrenie und Gewalt |
| Q47550304 | Should I Stay or Should I Go? FMRI Study of Response Inhibition in Early Illness Schizophrenia and Risk for Psychosis. |
| Q34028727 | Striatal dopamine release in schizophrenia comorbid with substance dependence |
| Q24643863 | Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? |
| Q35236689 | Substance abuse in patients with schizophrenia |
| Q35177137 | The impact of substance use on brain structure in people at high risk of developing schizophrenia |
| Q24067152 | The myth of schizophrenia as a progressive brain disease |
| Q37896626 | Understanding aberrant white matter development in schizophrenia: an avenue for therapy? |
| Q87945859 | [Frontal brain volume reduction due to antipsychotic drugs?] |
Search more.